REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/01/2025
Back to search
Official data from USPTO
TIGERMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
12/02/2025
Trademark type
Combined
Nice classes
42, 45
Filing date
10/31/2019
Registration date
12/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2020
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CN
Examiner
CANTONE,KERI H
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HANGZHOU TIGERMED CONSULTING CO., LTD.
Representatives
L. Jeremy Craft CRAFT CHU PLLC
Technical classification
Nice Classes
Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; pharmaceutical research services; research in the field of cosmeticspharmaceuticals and new products; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; laboratory research services relating to pharmaceuticals; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; scientific research for medical purposes in the area of cancerous diseases; conducting clinical trials for others being scientific research; medical research; chemicalbiochemicalbiological and bacteriological research and analysis; research and development services in the field of antibodies; blood analysis services; medical laboratory services; biomedical research services; testing of chemicals; computer programming in the medical field
Class 45
Chaperoning; online social networking services; intellectual property consultancy; licensing of software for management of intellectual property being legal services; licensing of intellectual property rights; legal administration of licences
Publications
History of USPTO decisions and trademark events.
23 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/02/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
03/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/15/2020
PUBO
PUBLISHED FOR OPPOSITION
09/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/23/2020
RFNT
REFUSAL PROCESSED BY IB
06/27/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/09/2020
RFRR
REFUSAL PROCESSED BY MPU
06/08/2020
MAFR
APPLICATION FILING RECEIPT MAILED
05/15/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/14/2020
CNRT
NON-FINAL ACTION WRITTEN
05/13/2020
DOCK
ASSIGNED TO EXAMINER
05/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/09/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/07/2020
Continuous trademark protection
Get notified about every new filing that threatens TIGERMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.